A novel PDHK inhibitor restored cognitive dysfunction and limited neurodegeneration without affecting amyloid pathology in 5xFAD mouse, a model of Alzheimer’s disease

By sjmartinez • September 6, 2024

Sakimura K, Kawai T, Nashida R, Ishida Y, Harada K, Suzuki T, Okuma C, Cole GM. A novel PDHK inhibitor restored cognitive dysfunction and limited neurodegeneration without affecting amyloid pathology in 5xFAD mouse, a model of Alzheimer's disease. Alzheimers Res Ther. 2024 Sep 5;16(1):197. doi: 10.1186/s13195-024-01552-2. PMID: 39238036.

Tags: 5xFAD, Aerobic glycolysis, Alzheimer’s disease, Geriatrics, Glucose metabolism, GRECC, PDH, PDHK, Publications, Pyruvate dehydrogenase, Pyruvate dehydrogenase kinase, Veterans Administration

Quadriceps mitochondrial DNA quantity, quality, and gene expression after 2 years of calorie restriction: exploratory results from the CALERIE trial

Das JK, Zhang Y, Redman LM, Martin CK, Das SK, Racette SB, Herbst A, Liu N, Allison DB, McKenzie D, Aiken JM, Horvath S, Candia[...]

Optimizing Primary Care Tools for Incontinence MAnagement (OPTIMA): protocol for a cluster randomized controlled trial

Moore MB, Okamuro K, Bresee C, Eskander R, Gin GT, Grisales T, Galvez A, Gregory K, Koola J, Lukacz ES, Mays AM, Nuckols TK, Pangelina[...]

Rational Use of Blood-Based Biomarkers for Alzheimer’s Disease: Navigating Between the Hope and the Hype

Reuben DB, Chambliss AB, Katz BJ, López AS, Hinman JD. Rational Use of Blood-Based Biomarkers for Alzheimer's Disease: Navigating Between the Hope and the Hype.[...]